Anagrelide as a new platelet-lowering agent in essential thrombocythemia: Mechanism of action, efficacy, toxicity, current indications

Ayalew Tefferi, Murray N. Silverstein, Robert M. Petitt, Ruben A. Mesa, Lawrence A. Solberg

Research output: Contribution to journal › Review article › peer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Anagrelide as a new platelet-lowering agent in essential thrombocythemia: Mechanism of action, efficacy, toxicity, current indications'. Together they form a unique fingerprint.

Medicine & Life Sciences